Icosavax
Public CompanyIcosavax develops virus-like particle vaccines targeting respiratory viruses such as RSV, hMPV, and COVID-19. Its platform uses computational protein design and virus-like particle scaffolds to create experimental vaccines intended to be shelf-stable and advance to clinical trials.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology, Vaccines, Life Sciences
- Status
- Public Company
- Stage
- Public
- Members see funding amounts. .
Is this your organization? Claim it
UW Institute for Protein Design and Nvidia open-source RFD4-Proteina model, claims 5–10× faster designs and higher success rates
The UW Medicine Institute for Protein Design and Nvidia released RFD4-Proteina, an open-source AI model that co-designs protein sequences and atomic structures and reportedly produces candidates 5–10× faster with 5–10× higher benchmark success rates. A UW student used the model to design an improved pesticide-degrading enzyme in days, and lab tests confirmed the model's outputs behaved as expected.
UW Institute for Protein Design and Nvidia unveil RFD4-Proteina, an open-source AI model for designing functional proteins after Jensen Huang GPU grant
UW’s Institute for Protein Design and Nvidia jointly released RFD4-Proteina, an open-source AI model for designing proteins with specific functions, developed after a major GPU grant from Nvidia CEO Jensen Huang’s foundation. IPD and director David Baker say the model is faster, more efficient, and could enable new medical, sustainability, and biotechnology applications.
Nobel Laureate David Baker Secures $7M from Washington Research Foundation for AI-Designed Protein Program at UW
Nobel Laureate David Baker received $7 million from the Washington Research Foundation to advance AI-designed protein research at the University of Washington. The initiative aims to develop designer enzymes for medicine, technology, and sustainability while fostering new scientists and startups.
See all 30 news stories about Icosavax.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Neil King Co-founder